IL103510A0 - Pharmaceutical compositions containing antibodies for causing immunosuppression - Google Patents
Pharmaceutical compositions containing antibodies for causing immunosuppressionInfo
- Publication number
- IL103510A0 IL103510A0 IL103510A IL10351092A IL103510A0 IL 103510 A0 IL103510 A0 IL 103510A0 IL 103510 A IL103510 A IL 103510A IL 10351092 A IL10351092 A IL 10351092A IL 103510 A0 IL103510 A0 IL 103510A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- containing antibodies
- causing immunosuppression
- immunosuppression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Transplantation (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4134982A DE4134982A1 (de) | 1991-10-23 | 1991-10-23 | Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103510A0 true IL103510A0 (en) | 1993-03-15 |
Family
ID=6443260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103510A IL103510A0 (en) | 1991-10-23 | 1992-10-22 | Pharmaceutical compositions containing antibodies for causing immunosuppression |
Country Status (17)
Country | Link |
---|---|
US (1) | US5951982A (cs) |
EP (1) | EP0538754B1 (cs) |
JP (1) | JPH05310596A (cs) |
KR (1) | KR100252620B1 (cs) |
AT (1) | ATE162079T1 (cs) |
AU (1) | AU659687B2 (cs) |
CA (1) | CA2081150C (cs) |
DE (2) | DE4134982A1 (cs) |
DK (1) | DK0538754T3 (cs) |
ES (1) | ES2111031T3 (cs) |
GR (1) | GR3026526T3 (cs) |
HU (1) | HU216020B (cs) |
IL (1) | IL103510A0 (cs) |
NO (1) | NO311965B1 (cs) |
NZ (1) | NZ244851A (cs) |
TW (1) | TW273514B (cs) |
ZA (1) | ZA928162B (cs) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589458A (en) * | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
EP0703989B1 (en) | 1993-06-18 | 1997-11-05 | Oy Biotie Therapies | COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
DE4326573A1 (de) * | 1993-08-07 | 1995-02-23 | Boehringer Ingelheim Int | Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren |
DE4431297A1 (de) * | 1994-09-02 | 1996-03-07 | Boehringer Ingelheim Int | Monoklonaler Antikörper gegen CD44v6 |
DE19540515C1 (de) * | 1995-10-31 | 1997-02-06 | Boehringer Ingelheim Int | Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten |
US6440733B1 (en) * | 1996-02-15 | 2002-08-27 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibodies recognizing antigens on the surface of endothelial cells of tumor vessel |
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
DE19652815C2 (de) * | 1996-12-18 | 1999-11-11 | Karlsruhe Forschzent | Mittel zur Identifizierung und Therapie metastasierender Tumore |
DE19653607A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Int | Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen |
DE19708713C2 (de) * | 1997-03-04 | 2002-11-28 | Boehringer Ingelheim Int | Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen |
IL121656A0 (en) * | 1997-08-29 | 1998-02-08 | Yissum Res Dev Co | Diagnosis prevention and treatment of diabetes |
US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
AU2003272511A1 (en) * | 2002-09-13 | 2004-04-30 | Dyax Corporation | Cd44-binding ligands |
US9701754B1 (en) | 2002-10-23 | 2017-07-11 | City Of Hope | Covalent disulfide-linked diabodies and uses thereof |
US20070280930A1 (en) * | 2004-03-17 | 2007-12-06 | Kasper Mathias Antoon Rouschop | Cd44-Targeting for Reducing/Preventing Ischemia-Reperfusion-Injury |
WO2007025166A2 (en) | 2005-08-25 | 2007-03-01 | Repair Technologies, Inc. | Devices, compositions and methods for the protection and repair of cells and tissues |
ATE509033T1 (de) | 2006-03-20 | 2011-05-15 | Univ California | Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting |
CA2698343C (en) | 2007-09-04 | 2018-06-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
WO2010058396A1 (en) | 2008-11-19 | 2010-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | A cd44vra antibody and diagnostic and therapeutic methods using same |
ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
EP3511023A1 (en) | 2009-12-02 | 2019-07-17 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
DK2886126T3 (en) | 2013-12-23 | 2017-09-18 | Exchange Imaging Tech Gmbh | Nanoparticle conjugated to CD44-binding peptides |
BR112017000710B1 (pt) | 2014-07-15 | 2024-02-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Polipeptídeo isolado, composição de matéria, e, uso do polipeptídeo isolado ou da composição da matéria |
EP3331564A4 (en) | 2015-08-07 | 2019-05-22 | Imaginab, Inc. | AGAINST MOLECULE TREATED ANTIGEN-BONDING CONSTRUCTS |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
US11313243B2 (en) | 2018-07-12 | 2022-04-26 | Rolls-Royce North American Technologies, Inc. | Non-continuous abradable coatings |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303463B1 (en) * | 1987-08-11 | 1994-11-30 | The Board Of Trustees Of The Leland Stanford Junior University | Method to control leukocyte extravasation |
DE4014510A1 (de) * | 1990-05-07 | 1991-11-14 | Kernforschungsz Karlsruhe | Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie |
CA2059824A1 (en) * | 1991-02-26 | 1992-08-27 | Thomas M. Aune | Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
EP0703989B1 (en) * | 1993-06-18 | 1997-11-05 | Oy Biotie Therapies | COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
-
1991
- 1991-10-23 DE DE4134982A patent/DE4134982A1/de not_active Withdrawn
-
1992
- 1992-10-07 TW TW081107971A patent/TW273514B/zh active
- 1992-10-17 AT AT92117775T patent/ATE162079T1/de not_active IP Right Cessation
- 1992-10-17 ES ES92117775T patent/ES2111031T3/es not_active Expired - Lifetime
- 1992-10-17 EP EP92117775A patent/EP0538754B1/de not_active Expired - Lifetime
- 1992-10-17 DK DK92117775.4T patent/DK0538754T3/da active
- 1992-10-17 DE DE59209129T patent/DE59209129D1/de not_active Expired - Fee Related
- 1992-10-21 NZ NZ244851A patent/NZ244851A/en unknown
- 1992-10-22 NO NO19924103A patent/NO311965B1/no not_active IP Right Cessation
- 1992-10-22 IL IL103510A patent/IL103510A0/xx unknown
- 1992-10-22 ZA ZA928162A patent/ZA928162B/xx unknown
- 1992-10-22 AU AU27244/92A patent/AU659687B2/en not_active Ceased
- 1992-10-22 HU HUP9203337A patent/HU216020B/hu not_active IP Right Cessation
- 1992-10-22 KR KR1019920019468A patent/KR100252620B1/ko not_active IP Right Cessation
- 1992-10-22 CA CA002081150A patent/CA2081150C/en not_active Expired - Fee Related
- 1992-10-23 JP JP4307913A patent/JPH05310596A/ja active Pending
-
1994
- 1994-12-20 US US08/359,850 patent/US5951982A/en not_active Expired - Lifetime
-
1998
- 1998-04-03 GR GR980400710T patent/GR3026526T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0538754B1 (de) | 1998-01-14 |
GR3026526T3 (en) | 1998-07-31 |
NO311965B1 (no) | 2002-02-25 |
NZ244851A (en) | 1997-07-27 |
ES2111031T3 (es) | 1998-03-01 |
NO924103L (no) | 1993-04-26 |
DK0538754T3 (da) | 1998-03-30 |
ZA928162B (en) | 1993-05-05 |
EP0538754A2 (de) | 1993-04-28 |
DE59209129D1 (de) | 1998-02-19 |
NO924103D0 (no) | 1992-10-22 |
CA2081150A1 (en) | 1993-04-24 |
KR100252620B1 (ko) | 2000-09-01 |
CA2081150C (en) | 2001-04-10 |
ATE162079T1 (de) | 1998-01-15 |
JPH05310596A (ja) | 1993-11-22 |
AU2724492A (en) | 1993-04-29 |
KR930007460A (ko) | 1993-05-20 |
US5951982A (en) | 1999-09-14 |
AU659687B2 (en) | 1995-05-25 |
HUT63063A (en) | 1993-07-28 |
TW273514B (cs) | 1996-04-01 |
DE4134982A1 (de) | 1993-04-29 |
HU216020B (hu) | 1999-04-28 |
EP0538754A3 (en) | 1994-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103510A0 (en) | Pharmaceutical compositions containing antibodies for causing immunosuppression | |
TW229208B (cs) | ||
IL128425A0 (en) | Taxane derivatives their preparation and pharmaceutical compositions containing them | |
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
FI931708A0 (fi) | Herbicida substituerade aryl-haloalkylpyrazoler | |
IL105727A (en) | 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them | |
NZ234501A (en) | Hemoregulatory peptides and pharmaceutical compositions containing them | |
IL87490A0 (en) | Pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for the treatment of alcoholism | |
AU626070B2 (en) | Anticoagulant peptide alcohols | |
PL332964A1 (en) | Bo-aromatic compound coupled ny intermediation of heteroethylene group and pharmaceutic and cosmetic containing such compounds | |
TW218011B (cs) | ||
ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
AU568694B2 (en) | N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine | |
IL103856A0 (en) | Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them | |
GB2204794B (en) | Nootropic pharmaceutical compositions containing triazine compounds | |
JO1711B1 (en) | Therapeutic agents | |
IT1261648B (it) | Processo di risoluzione ottica di tiopronina | |
DK1260222T3 (da) | Farmaceutiske præparater indeholdende hidtil ukendte iso-butenyl-substituerede taxaner |